CompoAtlas

Genestra Brands Femagen PMS Tablets

Natural health product licensed in Canada

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Magnésium

Source : Citrate de magnésium

100 milligramme200,000 µg
Bêta-carotène

Source : bêta-carotène

1,200 microgrammesNot calculated
Bos Taurus

Source : Ovaire

50 milligrammeNot calculated
Bos Taurus

Source : Glande surrénale

25 milligrammeNot calculated
Folate

Source : L-5 Méthyltétrahydrofolate, sel de calcium

150 microgrammesNot calculated
Fer

Source : Diglycinate de fer (II)

10 milligramme20,000 µg
Niacine

Source : Acide nicotinique

15 milligrammeNot calculated
Acide pantothénique

Source : D-Pantothénate de calcium

10 milligramme20,000 µg
Riboflavine

Source : Riboflavine

10 milligramme20,000 µg
Sus scrofa

Source : Cerveau

25 milligrammeNot calculated
Taraxacum officinale

Source : Feuille

10 milligrammeNot calculated
Thiamine10 milligramme20,000 µg
Vitamine B12

Source : Méthylcobalamine

25 microgrammesNot calculated
Vitamine B6

Source : Pyridoxal 5'-phosphate

50 milligramme100,000 µg
Vitamine E

Source : Succinate d'acide de d-alpha tocophéryle

34 mg ATNot calculated
Zinc

Source : Citrate de zinc

5 milligramme10,000 µg
Calcium

Source : Citrate de calcium

50 milligramme100,000 µg
Vitex agnus-castus

Source : Fruit

Extract : Matériel brut sec

Extraction ratio : 7-10:1

Dry plant equivalent : 350-500 mg

50 milligrammeNot calculated
Choline

Source : Bitartrate de choline

15 milligrammeNot calculated

Non-medicinal ingredients

Hypromellose, Glycérine, Silice, Cellulose, Croscarmellose de sodium, Hydroxypropylcellulose, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Comprimé2 Tous les jours

Uses authorised in Canada

Provitamin A for the maintenance of good health. Provitamin A to help maintain eyesight, skin, membranes and immune function. Provitamin A to help in the development and maintenance of night vision. Provitamin A to help in the development and maintenance of bones and teeth. Helps to form red blood cells. Helps to support normal early fetal development. Helps to support normal early development of the fetal brain and spinal cord. Helps normal growth and development. Helps in energy metabolism and tissue formation. Helps to maintain the body's ability to metabolize nutrients. Helps to maintain healthy mucous membranes. Helps to maintain normal red blood cells. Helps to maintain normal metabolism of iron. Helps in energy production. Helps in the normal function of the immune system. Helps to form red blood cells and helps in their proper function. Helps to reduce tiredness and fatigue caused by iron deficiency anemia. Helps pregnant women meet (the) (Health Canada's) recommended intake for iron, when taken in conjunction with a healthy diet. Helps to prevent iron deficiency. Helps to prevent iron deficiency anaemia. Helps to prevent iron deficiency anemia and associated tiredness and fatigue. Helps in the development and maintenance of bones and teeth. Helps to maintain proper muscle function. Helps to maintain proper muscle function, including the heart muscle. Source of/An electrolyte for the maintenance of good health. Helps in energy metabolism, tissue formation and bone development. Helps to maintain normal electrolyte balance. Used in Herbal Medicine to help relieve premenstrual symptoms. Used in Herbal Medicine as a hormone normaliser to help stabilise menstrual cycle irregularities. Used in Herbal Medicine to help relieve symptoms associated with menopause, such as hot flushes.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Seroyal International
NPN or DIN-HM
80082517
Status
Active licence
Licence date
19 January 2018
Revision date
15 May 2024
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80082517

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vitex agnus-castus
    Read the warning, when it applies and the studies cited

    CHASTE TREE - VITEX AGNUS-CASTUS

    Route of administration: Oral (WHO 2009; Bradley 2006; Mills and Bone 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy (Brinker 2010; WHO 2009; Bradley 2006).

    Sources cited by Health Canada (4)
    • Bradley PR, editor. 2006. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • WHO 2009: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 4. Geneva (CH): World Health Organization.
    • OMS 2009: Organisation mondiale de la santé. WHO Monographs on Selected Medicinal Plants, Volume 4. Genève (CH): Organisation mondiale de la santé.

    Contraindications

    Do not use if you are pregnant, breastfeeding or attempting to conceive unless you have consulted with a health care practitioner/health care provider/health care professional/doctor/physician (EMA 2018; Najib et al. 2022; Brinker 2010; WHO 2009; Dugoua et al. 2008; ESCOP 2003; Blumenthal 2000; Mills and Bone 2000).

    Sources cited by Health Canada (9)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. 2000. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Dugoua JJ, Seely D, Pern D, Koren G, Mills E. Safety and efficacy of chastetree (Vitex Agnus-Castus) during pregnancy and lactation. Can J. Clin Pharmacol 2008;15(1);e74-e79.
    • EMA 2018. European Medicines Agency. European Union herbal monograph on Vitex agnus-castus L., fructus. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 27 March 2018. [Accessed 2024 February 29] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-vitex-agnus-castus-l-fructus-revision-1_en.pdf
    • ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy in collaboration with Thieme.
    • Mills S, Bone K. 2000. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone.
    • Najib FS, Poordast T, Mahmudi MS, Shiravani Z, Namazi N, Omrani GR. Does Vitex Agnus-Castus L. Have Deleterious Effect on Fertility and Pregnancy Outcome? An Experimental Study on Rats for Prediction of Its Safety. J. Pharmacopuncture 2022;25(2):106-113. PubMed
    • WHO 2009: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 4. Geneva (CH): World Health Organization.
    • OMS 2009: Organisation mondiale de la santé. WHO Monographs on Selected Medicinal Plants, Volume 4. Genève (CH): Organisation mondiale de la santé.

    Health Canada monograph dated 28 March 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Photograph the packaging

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Genestra Brands Femagen PMS Tablets (Seroyal International): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80082517-genestra-brands-femagen-pms-tablets, updated 15 May 2024.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line